Skip to main navigation Skip to search Skip to main content

Clinical impact of primary prophylactic pegfilgrastim in breast cancer patients receiving adjuvant docetaxel-doxorubicin-cyclophosphamide chemotherapy

  • The Catholic University of Korea, St. Vincent's Hospital

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical impact of primary prophylactic pegfilgrastim in breast cancer patients receiving adjuvant docetaxel-doxorubicin-cyclophosphamide chemotherapy'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science